BLBeiyu Liu

Beiyu Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Beiyu Liu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Teledermatology May Benefit Marginalized Populations: National and Institutional Trends during the COVID-19 Pandemic

    by Akash D. Patel, Chandler W. Rundle, Beiyu Liu, Cynthia L. Green, Christian L. Bailey-Burke, Meenal Kheterpal

    Introduction Limited data exist regarding demographic-specific teledermatology (TD) utilization during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine TD utilization trends during the pandemic. Methods A retrospective cohort study for national and institutional populations was conducted. Patient encounters in the American Academy of Dermatology’s DataDerm registry (DataDerm) were analyzed from 1 April 2020 through 30 June 2021. All dermatological patients seen by Duke University Health Systems (DUHS) were analyzed from 1 March 2020 through 30 April 2021. In-person clinic visits versus TD encounters (national and institutional) and no-show rates (institutional only) were collected for visit type (i.e., TD versus in-person), sex, race, age/generation, and in- versus out-of-state location (national only). TD utilization is defined as the cohort of interest using TD (e.g., females, whites) within a demographic group (i.e., sex, race) as a percentage of total TD users. This was compared with in-person utilization during the identical timeframe. Results For US national data, 13,964,816 encounters were analyzed. Sex, race, age, and location each had a significant association with TD utilization (adjusted p < 0.001). For institutional data, 54,400 encounters were analyzed. Sex, race, and age had a significant association with TD utilization (adjusted p < 0.001). Both datasets revealed majority female populations for telehealth visits (DataDerm 66.0%; DUHS 61.7%). Non-white populations accounted for a higher percentage of TD utilizers (DataDerm 15.0%; DUHS 37.3%) when compared with in-person utilizers (DataDerm 11.7%; DUHS 22.3%). Younger patients utilized TD (DataDerm 63.6%; DUHS 62.6%) more than in-person services (DataDerm 26.3%; DUHS 43.8%). Institutional no-show rates between telehealth and in-person visits were lower for Black patients (11.8% versus 19.2%), other non-white races (10.6% versus 13.6%), and younger ages/generations (9.8% versus 12.8%), respectively. TD utilization decreased over time nationally as a percentage of total visits (2.9% versus 0.3%) in 2020 versus 2021, respectively. Conclusions and Relevance During the COVID-19 pandemic, certain populations (females, younger patients, non-white races) showed higher TD utilization. Understanding TD utilization trends is critical in defining the role of virtual care for improving universal care access, optimizing resources, and informing future healthcare models for all patient populations.


  • Open Access

    Clinicopathologic Characteristics of Melanoma in Patients with Parkinson Disease

    by M. Seth Flynn, Camille Robinson, Surya Patel, Beiyu Liu, Cynthia Green, Michelle Pavlis


  • High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa

    by Simon W. Jiang, Jeffery T. Kwock, Beiyu Liu, Amy J. Petty, Aaron T. Zhao, Cynthia L. Green, Tarannum Jaleel

    In this case series, ustekinumab therapy demonstrated efficacy in some patients with severe hidradenitis suppurativa previously treated with adalimumab and/or infliximab. Larger prospective studies are needed to evaluate ustekinumab as a treatment option for recalcitrant hidradenitis suppurativa.


  • Impact of pharmacist outreach on glucagon prescribing

    by Nakiya Whitfield, Patrick Gregory, Beiyu Liu, Susan Spratt, Benjamin H. Smith


  • Impact of a Real-Time, Pharmacist-Led, Intensive Care Unit–Based Feedback Intervention on Analgesia and Sedation Quality Among Mechanically Ventilated Patients

    by Benjamin PharmD Mancheril, Bridgette PharmD Kram, Jennifer PharmD Schultheis, Shawn PharmD Kram, Morgan PharmD Trammel, Beiyu Liu, Weston Jordan, Christopher E. Cox

    Background: Consensus guidelines for pain, agitation, and delirium (PAD) in mechanically ventilated patients recommend maintaining a light level of sedation. Local Problem: Consistent attainment of target PAD assessments in mechanically ventilated ICU patients is often challenging. Methods: This is a single-center, prospective study. Interventions: In the intervention group, a pharmacist provided weekly feedback to nurses on their success in achieving target PAD assessments compared with a historical cohort without feedback. Results: Overall, 478 patients and 205 nurses were included. The odds of having weekly Richmond Agitation-Sedation Scale (RASS) score, pain score goals, and Confusion Assessment Method for the ICU (CAM-ICU) negative assessments at goal between the intervention and control groups fluctuated over time without a discernible trend. Conclusion: The provision of weekly feedback to nurses on PAD nursing assessments by a pharmacist did not impact the achievement of PAD goals among critically ill mechanically ventilated patients.